Revenue
1.37 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 1365000 USD Source
Annual consolidated revenue for 2025: about USD 6.547M, using the latest reported figures.
1.37 million USD
2026 Q2 · USD
-728.35%
2026 Q2 · %
-12.4 million USD
2026 Q2 · USD
-12.4 million USD
2026 Q2 · USD
4102000 USD
17206000 USD
13210122 shares
118.74% · 7.17 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
10.8 million USD
2025-07-01 – 2026-06-30
-536 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-26.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 14.18 million
–
Current period
−USD 450.52 million
–
-450521000 − -14180000 = -436341000 USD
-14180000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-450521000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.17 million
–
Current period
−USD 26.05 million
–
-26052000 − -1171000 = -24881000 USD
-1171000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-26052000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2025 2025-01-01 – 2025-12-31 | 6547000 | 239997000 Derived | -233450000 | 217071000 Derived | -450521000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Revenue | 6547000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Operating margin | -3,565.8% |
|
| 2025 | Net margin | -6,881.3% |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Operating cash flow | -26052000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Liabilities / assets | 21.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2025 | Current assets / current liabilities | 0.33× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | USD 123,764 Exact valueExact value: 123764 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 497,357 Exact valueExact value: -497357 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | USD 1.04 million Exact valueExact value: 1040542 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 789,230 Exact valueExact value: -789230 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 25.39 million Exact valueExact value: -25394046 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.32 million Exact valueExact value: -3318654 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 10.88 million Exact valueExact value: -10884058 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.87 million Exact valueExact value: -3871961 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 20.32 million Exact valueExact value: -20324648 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19.37 million Exact valueExact value: -19371428 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 38.73 million Exact valueExact value: -38726259 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.13 million Exact valueExact value: -12127585 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 19.94 million Exact valueExact value: -19935112 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10.92 million Exact valueExact value: -10922223 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 14.18 million Exact valueExact value: -14180000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.17 million Exact valueExact value: -1171000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 450.52 million Exact valueExact value: -450521000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26.05 million Exact valueExact value: -26052000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
89 filings · 2,000 latest values · 2,000 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001690080, 1690080, ATNF, ETHZ, FRMM, KBLM, KBLMU, edgar:1690080
Also known as 180 LIFE SCIENCES CORP, 180 LIFE SCIENCES CORP., 180 Life Sciences Corp., ETHZilla Corp, ETHZilla Corporation, FORUM MARKETS Inc, Forum Markets, Incorporated, KBL MERGER CORP. IV